AMPK agonists restored muscle cell activity impaired by TNFα and IFNγ and partly alleviated SMW in a transplant model of colon cancer, associated with increased oxidative metabolism (Hall et al., 2018). The gene discussed is IFNG; the disease is malignant colon neoplasm.